- Home
- AZTA vs APGE Comparison
AZTA vs APGE Comparison
Compare AZTA & APGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AZTA
- APGE
- Stock Information
- Founded
- AZTA 1978
- APGE 2022
- Country
- AZTA United States
- APGE United States
- Employees
- AZTA N/A
- APGE N/A
- Industry
- AZTA Industrial Machinery/Components
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AZTA Technology
- APGE Health Care
- Exchange
- AZTA Nasdaq
- APGE Nasdaq
- Market Cap
- AZTA 1.8B
- APGE 2.1B
- IPO Year
- AZTA 1995
- APGE 2023
- Fundamental
- Price
- AZTA $29.64
- APGE $41.96
- Analyst Decision
- AZTA Buy
- APGE Strong Buy
- Analyst Count
- AZTA 3
- APGE 4
- Target Price
- AZTA $50.67
- APGE $91.33
- AVG Volume (30 Days)
- AZTA 703.4K
- APGE 785.6K
- Earning Date
- AZTA 08-05-2025
- APGE 08-11-2025
- Dividend Yield
- AZTA N/A
- APGE N/A
- EPS Growth
- AZTA N/A
- APGE N/A
- EPS
- AZTA N/A
- APGE N/A
- Revenue
- AZTA $669,171,000.00
- APGE N/A
- Revenue This Year
- AZTA N/A
- APGE N/A
- Revenue Next Year
- AZTA $4.89
- APGE $743.14
- P/E Ratio
- AZTA N/A
- APGE N/A
- Revenue Growth
- AZTA 8.56
- APGE N/A
- 52 Week Low
- AZTA $23.91
- APGE $26.20
- 52 Week High
- AZTA $63.58
- APGE $63.50
- Technical
- Relative Strength Index (RSI)
- AZTA 54.22
- APGE 56.93
- Support Level
- AZTA $29.16
- APGE $40.67
- Resistance Level
- AZTA $30.86
- APGE $44.65
- Average True Range (ATR)
- AZTA 1.18
- APGE 2.48
- MACD
- AZTA 0.13
- APGE 0.18
- Stochastic Oscillator
- AZTA 70.88
- APGE 70.41
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.